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Decades of bioprocess optimization have resulted in substantial 
improvements in recombinant protein production. However, some 
proteins remain difficult to express, and there is an increasing 
awareness of the need for improved control of critical quality 
attributes of recombinant protein drugs. To enable cell engineering 
efforts to enhance protein production and control product quality, we 
have enumerated the CHO cell parts through genome sequencing 
efforts,1,2 and are now providing context to these parts by 
reconstructing genome-scale networks of the secretory pathway, 
glycosylation, and metabolism CHO (Figure 1). Using these models, 
which account for the activities of more than 2000 genes, we have 
approached questions relevant to bioprocessing and guided cell 
engineering efforts.  
 
First, several bioprocess treatments have increased CHO cell 
specific productivity, but the yields still pale in comparison to 
professional secretory cells. Have these bioprocess treatments 
maximized specific productivity? To answer this question, 
transcriptomic, proteomic and metabolomic data were used build 
cell-line specific models. Through simulations we found that 
common treatments, such as NaBu and decreased temperature 
increase the yield inefficiently, as opposed to cell engineering 
efforts.  
 
Second, cell engineering efforts aim to match product quality 
attributes relevant to product activity. To aid in this, we developed a 
simple but powerful computational modeling platform to predict 
glycosylation and study how metabolism impacts glycans on 
products. Using this platform and an initial glycoprofile of a product 
under development, we can successfully predict the effects of genetic manipulations and media, thereby 
providing insights into which treatments are most likely to yield the desired glycoforms.  
 
In summary, these genome-scale models serve as valuable platforms for data analysis and simulation, thereby 
providing insights into the molecular basis of various bioprocess phenotypes and for guiding cell engineering 
efforts.  
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Figure 1 – We have reconstructed the 
pathways underlying the CHO secretory 
pathway, including protein translation, 
glycosylation and cell metabolism. These 
pathways are valuable resources for the 
analysis of genomic variants, 
glycosylation, and cell processes 
impacting product quality.  
